Clinical trial Recruiting at 1 site Interventional Ages 35 to 50 Men only

TECAR therapy added to physical therapy for chronic discogenic sciatica

Official title: Effect of Capacitive and Resistive Energy Transfer on Pain, Functional Outcome and Electrophysiological Parameters in Patients With Chronic Discogenic Sciatica

Run by Cairo University · NCT07841405 · Data updated 2026-11-12

This study tests whether adding TECAR therapy to a standard physical therapy program helps reduce pain and improve function in adults with chronic discogenic sciatica.

Quick facts

Study typeInterventional
Ages35 Years to 50 Years
SexMen only
Enrollment34 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Giza)
StatusRecruiting
StartedSeptember 21, 2026
Main results expectedJanuary 21, 2027
Study endsJanuary 21, 2027
Registry record updatedOctober 29, 2026
Trial IDNCT07841405 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 30–50 with unilateral, MRI-confirmed chronic discogenic sciatica at L5–S1, lasting >3 months, pain score ≥4, and able to participate in outpatient therapy.

Probably not a fit

Patients without a favorable response to TECAR therapy or with exclusion criteria (such as prior lumbar surgery or metallic implants) may not experience additional benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 30–50 with unilateral L5–S1 discogenic sciatica persisting more than 3 months will be randomized to receive either TECAR therapy in addition to conventional physical therapy or conventional physical therapy alone. The trial will compare changes in pain, functional disability, and electrophysiological measures (H-reflex latency and amplitude) between groups. TECAR therapy is delivered alongside the usual TENS, hot packs, stretching, and core exercises to see if it provides added benefit. The study is conducted at Cairo University’s Faculty of Physical Therapy in Egypt under an interventional framework.

Why it matters

Potential benefit: If TECAR therapy provides additional benefit, patients may experience greater pain relief and improved function.

How similar studies have gone: Previous studies with similar energy-based modalities have shown mixed results; this approach is building on prior work but remains relatively novel in this specific context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 30-50 years
* Unilateral chronic discogenic sciatica at L5-S1, MRI confirmed
* Symptom duration more than 3 months
* Pain score ≥ 4 on the Visual Analogue Scale (VAS)
* Ability to participate in outpatient physiotherapy

Exclusion Criteria:

* Previous lumbar spine surgery
* Pacemaker or metallic implants
* Peripheral neuropathy or systemic neurological disorders
* Severe sensory loss
* Skin lesions at the treatment site
* Recent corticosteroid injection (\< 3 weeks)

Where it's running

  • Faculty of Physical Therapy Cairo University
    Giza, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.